Ovarian atrophy

Also known as: Acquired atrophy of ovary / Acquired atrophy of ovary, unspecified side / Atrophy ovary / Senile involution of ovary (disorder) / Acquired atrophy of ovary (disorder)

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB01524	Androstenediol	Androstenediol is an intermediate in testosterone biosynthesis, found in the testis or the adrenal glands. Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted...
DB01536	Androstenedione	A delta-4 C19 steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as...

Drug	Drug Name	Target	Type
DB01536	Androstenedione	Aldo-keto reductase family 1 member C3	target
DB01536	Androstenedione	Estradiol 17-beta-dehydrogenase 1	target
DB01536	Androstenedione	6-deoxyerythronolide B hydroxylase	target
DB01536	Androstenedione	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	target
DB01536	Androstenedione	Cytochrome P450 3A4	enzyme
DB01536	Androstenedione	Aldo-keto reductase family 1 member C3	enzyme

Drug	Drug Name	Phase	Status	Count